Key Takeaways
- The FDA classifies dietary supplements as food, not drugs, resulting in minimal pre-market regulation.
- Most brain supplements lack robust scientific evidence for cognitive benefits, despite widespread marketing.
- The supplement industry has grown significantly, from 4,000 products in 1994 to 90,000, with limited oversight.
- Misinformation about supplement efficacy spreads easily, particularly on social media platforms like TikTok.
- Proposed regulatory reforms advocate for stricter scientific evidence and a "guilty until proven innocent" standard for new ingredients.
Deep Dive
- The Dietary Supplement Health and Education Act of 1994 (DSHEA) classifies supplements as a type of food, not pharmaceuticals.
- This classification means the FDA does not strictly regulate supplements for safety or efficacy before they reach the market.
- The U.S. supplement industry is estimated at $45 billion annually, with manufacturers able to make broad claims like 'maintains healthy memory' without scientific substantiation.
- Unlike pharmaceutical companies, which require rigorous FDA approval and clinical trials for specific claims, supplement manufacturers operate with little to no oversight.
- The supplement industry has seen massive growth from 4,000 products in 1994 to 90,000, with no pre-market health agency approval.
- A 2025 Consumer Reports analysis found two-thirds of protein powders and shakes contained excessive lead, highlighting manufacturing competency issues.
- Approximately 23,000 emergency department visits annually in the U.S. are linked to adverse effects from dietary supplements.
- While some supplements like magnesium and B vitamins can address deficiencies, others like creatine, choline, and Ginkgo biloba lack robust data for cognitive benefits.
- For example, the NIH-funded Ginkgo Evaluation of Memory study showed no cognitive benefits from Ginkgo biloba compared to a placebo.
- The origin of a substance, whether from a lab or a plant, is less important than its standardized components, ratios, and absorption into the body, according to physician Pieter Cohen.
- Examples include red yeast rice, which contains monocolin K (identical to the statin drug lovastatin), and galantamine, found naturally and synthesized pharmaceutically.
- A study found pharmaceutical versions of galantamine were accurately labeled, while supplement versions varied widely in quantity and some were contaminated with bacteria.
- Physicians Peter Cohen and Peter Attia express skepticism towards many dietary supplements but suggest magnesium and creatine monohydrate as generally beneficial options.
- Omega-3 fatty acids (EPA and DHA) are recommended due to insufficient dietary intake from fish, while melatonin and phosphatidylserine are for specific uses.
- GLP-1 agonists show promising cognitive benefits, particularly in patients with mild cognitive impairment, with more robust study evidence than most supplements.
- Cognitive function encompasses executive function, memory, and processing speed, all of which can decline with age.
- A skilled clinician can assess these domains, but prioritizing foundational lifestyle factors is crucial.
- These foundational factors include sleep, exercise, nutrition, and social and intellectual engagement, which should be optimized before considering supplements.
- Understanding of the brain is limited, and information on brain supplements often comes from diverse, unreliable channels like social media.
- Guests Peter Attia and Peter Cohen express frustration with the ease of spreading misinformation about supplements on platforms like TikTok.
- This rapid spread of unverified claims is contrasted with the complex, evidence-based lifestyle changes like exercise that Attia advocates for.
- Physician Pieter Cohen proposes potential regulatory improvements, including an FDA registry for approved dietary supplement products.
- Marty Makary, FDA Commissioner, advocates for changing the Generally Recognized As Safe (GRAS) standard to a 'guilty until proven innocent' approach for new chemicals in the food supply, especially for children.
- Despite concerns from manufacturers, the current political climate is described as moving towards less strict oversight, with manufacturers advocating for more claim abilities and FDA endorsement.